Vaccination of tumor cells transfected with the B7-1 (CD80) gene induces the anti-metastatic effect and tumor immunity in mice

International Journal of Cancer

Volumn 66, Issue 2, 1996, Pages 219-224

  Fujii, Hideki ^a,b   Inobe, Manabu ^b   Kimura, Fuminari ^a   Murata, Jun ^a   Murakami, Masaaki ^b   Onishi, Yasuharu ^a   Azuma, Ichiro ^b   Uede, Toshimitsu ^b   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNE RESPONSE; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; VACCINATION;

ANIMALS; ANTIGENS, CD80; FEMALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES; TRANSFECTION; VACCINATION;

EID: 0029885278     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960410)66:2<219::AID-IJC14>3.0.CO;2-7     Document Type: Article

References (21)

1. AZUMA, I. and SAIKI, I., Prevention of cancer metastasis in mice with fibronectin-related substances. In: S. Hirohashi, H.L. Moses, E. Ruoslahti, T. Sugimura, M. Takeichi and M. Terada (eds), Proceeding of the International Symposium of the Princess Takamatsu Cancer Research Fund: Molecular and cellular basis for cell to cell interaction: its significance in cancer, pp. 125-141, Princeton Scientific, Princeton (1994).
2. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. exp. Med., 181, 619-629 (1995).
3. BASKAR, S., OSTRAND-ROSENBERG, S., NABAVI, N., NADLER, L.M., FREEMAN, G.J. and GLIMCHER, L.H., Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. nat. Acad. Sci. (Wash ). 90, 5687-5690 (1993).
4. CHEN, L., ASHA, S., BRADY, W.A., HELLSTROM, I., LEDBETTER, J.A., MCGOWAN, P. and LINSLEY, P.S., Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71, 1093-1102 (1992).
5. CHEN, L., MCGOWAN, P., ASHE, S., JOHNSTON, J., LI, Y., HELLSTROM, I. and HELLSTRÖM, K.E., Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. exp. Med., 179, 523-532 (1994).
6. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D. and MULLIGAN, R., Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. nat. Acad. Sci. (Wash.), 90, 3539-3543 (1993).
7. FIDLER, I.J., The Ernst W. Bertner Memorial Award Lecture: The evolution of biological heterogeneity in metastatic neoplasmas. In: G.L. Nicolson and L. Milas (eds.), Cancer invasion and metastasis: biologic and therapeutic aspects, pp. 5-26, Raven Press, New York (1984).
8. GOLUMBEK, P., LAZENBY, A., LEVITSKY, H., JAFFEE, E., KARASYYAMA, H., BAKER, M. and PARDOLI, D., Treatment of established renal cancer by tumor cells engineered to secrete interleukm-4. Science, 254, 713-716 (1991).
9. HART, I.R., The selection and characterization of an invasive variant of the B16 melanoma Amer. J. Pathol., 97, 587-592 (1979).
10. HUMPHRIES, M.J., OLDEN, K. and YAMADA, K.M., A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science, 233, 467-470 (1986).
11. INOBE, M., LINSLEY, P.S., LEDBETTER, J.A., NAGAI, Y., TAMAKOSI, M. and UEDE, T., Identification of an alternatively spliced form of the murine homologue of B7. Biochem. biophys. Res. Comm., 200, 443-449 (1994).
12. IWAMOTO, Y., ROBEY, F.A., GRAF, J., SASAKI, M., KLEINMAN, H.K., YAMADA, Y. and MARTIN, G.R., YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science, 237, 1132-1134 (1987).
13. LIOTTA, L.A., RAO, C.V. and BARSKY, S.H., Tumor invasion and the extracellular matrix. Lab. Invest., 49, 636-649 (1983).
14. MCCARTHY, J.B., SKUBITZ, A.P.N., PALM, S.L. and FURCHT, L.T., Metastasis inhibition of different tumor types by purified laminin fragments and a heparin-binding fragment of fibronectin. J. nat Cancer Inst., 80, 108-116 (1988).
15. MUELLER, D.L., JENKINS, M.K. and SCHWARTZ, R.H., Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Ann. Rev. Immunol., 7, 445-480 (1989).
16. NICOLSON, G.L., Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncofetal expression. Cancer Res., 47, 1473-1487 (1987).
17. SAIKI, I., ILDA, J., MURATA, J., OGAWA, R., NISHI, N., SUGIMURA, K., TOKURA, S. and AZUMA, I., Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequence of cell adhesive molecules. Cancer Res., 49, 3815-3822 (1989a).
18. SAIKI, I., MURATA, J., ILDA, J., SAKURAI, T., NISHI, N., MATSUNO, K. and AZUMA, I., Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) sequences. Brit. J. Cancer, 60, 722-728 (19896).
19. TAHARA, H., ZEH, H., STORKUS, W., PAPPO, I., WATKINS, S., GUBLER, U., WOLF, S., ROBBINS, P. and LOTZE, M., Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res., 54, 182-189 (1994).
20. + T cells by B7-transfected melanoma cells. Science, 259, 368-370 (1993).
21. TOWNSEND, S.E., SU, F.W., ATHERTON, J.M. and ALLISON, J P., Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res., 54, 6477-6483 (1994).